| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020703 |
| Receipt No. | R000023883 |
| Scientific Title | Research on Evaluating Stress Accumulation in an Isolation Environment that Simulate a Long Duration Space Mission |
| Date of disclosure of the study information | 2016/01/22 |
| Last modified on | 2021/06/24 (Ver. 17) |
| Basic information | ||
| Public title | Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission |
|
| Acronym | Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission |
|
| Scientific Title | Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission |
|
| Scientific Title:Acronym | Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission |
|
| Region |
|
|
| Condition | |||
| Condition | Healthy adult male only, or healthy adult male and female | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | To narrow down stress markers that reflect a level of the stress objectively when placing a workload on participants in an isolated environment |
| Basic objectives2 | Others |
| Basic objectives -Others | To narrow down stress markers that reflect a level of the stress objectively when placing a workload on participants in an isolated environment |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Narrowing down stress markers that reflect a level of the stress objectively |
| Key secondary outcomes | Changes in stress marker candidate levels when placing a workload on participants in an isolated environment |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1)Prohibition on leaving the Isolation Chamber for 14 days, 2)Following the designated plan (to sleep/wake up at designated time, to perform tasks according to schedule), 3)Personal space available only in each sleeping compartment and bathroom/restroom, 4)No information and communication equipment, no internet usage, no game machines, no smoking, 5)Restriction on meals (only preserved foods simulating space foods being provided, and no caffeinated drinks or alcohol beverages allowed), 6)Restriction on hygiene (allowing for only short-time showers), 7)Restriction on exercise (First 8 subjects-muscle training permitted, second 8 subjects-exercise prohibited, third 8 subjects-50% VO2max bike exercise conducted for 15 min every day with other exercise prohibited) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. adult male only, or adult male and female
2. would like to participate closed chamber study as a subject. 3. agree with informed consent |
|||
| Key exclusion criteria | 1. have presence of chronic illness or medication
2. smoker 3. alcoholic, drug abuse 4. claustrophobia 5. food allergy 6. in the caused ill feelings by blood collection. 7. serious medical history (cerebrovascular disease, heart disease) 8. positive for tuberculosis test 9. are prohibited to participate in trail by safety manager |
|||
| Target sample size | 56 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japan Aerospace Exploration Agency | ||||||
| Division name | Human Spaceflight Technology Directorate | ||||||
| Zip code | |||||||
| Address | 2-1-1, Sengen, Tsukuba, Ibaraki, 305-8505, Japan | ||||||
| TEL | +81-50-3362-7648 | ||||||
| furukawa.satoshi@jaxa.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan Aerospace Exploration Agency | ||||||
| Division name | Human Spaceflight Technology Directorate | ||||||
| Zip code | |||||||
| Address | 2-1-1, Sengen, Tsukuba, Ibaraki, 305-8505, Japan | ||||||
| TEL | +81-50-3362-3528 | ||||||
| Homepage URL | |||||||
| inoue.natsuhiko@jaxa.jp | |||||||
| Sponsor | |
| Institute | Japan Aerospace Exploration Agency |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Aerospace Exploration Agency |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | University of Tsukuba, University of Tokyo, National Defense Medical College, Shiseido, Yakult, Cellspect, KAKENHI'Living In Space' |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 筑波宇宙センター(茨城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | Submitted for publication |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Observe using video camera |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023883 |